Coverage
-
September 24, 2014
Vertex Pharmaceuticals Inc. and Gilead Sciences Inc. asked a Massachusetts federal judge on Wednesday to dismiss a trade-secrets suit accusing Gilead of poaching a high-level Vertex employee with access to confidential data on its soon-to-be-discontinued Incivek hepatitis C drug, after they reached a settlement.
1 other articles on this case.
View all »